Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OTLK
OTLK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OTLK News
Outlook Therapeutics Expects Approval for LYTENAVA
4d ago
stocktwits
FDA Reconsiders ONS-5010 Marketing Application for Wet AMD
4d ago
seekingalpha
Outlook Therapeutics' FDA Resubmission Acknowledged for ONS-5010
4d ago
Newsfilter
Outlook Therapeutics Resubmits Lytenava Application to FDA for Approval
Jun 01 2026
stocktwits
Outlook Therapeutics Resubmits BLA for ONS-5010/LYTENAVA™ Approval
Jun 01 2026
Newsfilter
Outlook Therapeutics Prices $5 Million Stock Offering
May 29 2026
NASDAQ.COM
SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm
May 29 2026
NASDAQ.COM
Outlook Therapeutics Completes Stock Offering
May 28 2026
Yahoo Finance
FDA Approves Eye Disease Drug Lytenava, Shares Surge
May 28 2026
stocktwits
Multiple Companies See Significant Stock Price Gains
May 27 2026
NASDAQ.COM
RDW Stock Rises 26% Amid Space Sector Euphoria Following SpaceX Debut
May 27 2026
stocktwits
Outlook Therapeutics Shares Surge 38% After FDA Appeal Win
May 26 2026
NASDAQ.COM
FDA Grants Approval for OTLK Eye Disease Treatment
May 26 2026
stocktwits
Outlook Therapeutics Secures FDA Approval for ONS-5010
May 26 2026
NASDAQ.COM
Outlook Therapeutics Reports Q2 Earnings Miss
May 15 2026
seekingalpha
Outlook Therapeutics Announces $5M Stock Offering of 16.12M Shares
Apr 22 2026
seekingalpha
Show More News
